Bridgeway Capital Management’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54K | Hold |
|
|||||
|
2025
Q1 | $57.3K | Hold |
|
|||||
|
2024
Q4 | $64.8K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $51.2K | Buy |
|
|||||
|
2024
Q1 | $113K | Sell |
|
|||||
|
2023
Q4 | $151K | Hold |
|
|||||
|
2023
Q3 | $149K | Hold |
|
|||||
|
2023
Q2 | $207K | Sell |
|
|||||
|
2023
Q1 | $289K | Hold |
|
|||||
|
2022
Q4 | $188K | Buy |
|
|||||
|
2022
Q3 | $130K | Hold |
|
|||||
|
2022
Q2 | $144K | Hold |
|
|||||
|
2022
Q1 | $163K | Sell |
|
|||||
|
2021
Q4 | $267K | Hold |
|
|||||
|
2021
Q3 | $372K | Hold |
|
|||||
|
2021
Q2 | $501K | Buy |
|